APA (7th ed.) Citation

Kitoh, T. (2026). From ALL to Myeloid and NK Malignancies: Operationalizing "ASNS-Low" for L-Asparaginase Repurposing and Combination Therapy. Biomolecules (2218-273X), 16(6), 792. https://doi.org/10.3390/biom16060792

Chicago Style (17th ed.) Citation

Kitoh, Toshiyuki. "From ALL to Myeloid and NK Malignancies: Operationalizing "ASNS-Low" for L-Asparaginase Repurposing and Combination Therapy." Biomolecules (2218-273X) 16, no. 6 (2026): 792. https://doi.org/10.3390/biom16060792.

MLA (9th ed.) Citation

Kitoh, Toshiyuki. "From ALL to Myeloid and NK Malignancies: Operationalizing "ASNS-Low" for L-Asparaginase Repurposing and Combination Therapy." Biomolecules (2218-273X), vol. 16, no. 6, 2026, p. 792, https://doi.org/10.3390/biom16060792.